{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:49:39Z","timestamp":1790023779773,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["BMU2021MX003"],"award-info":[{"award-number":["BMU2021MX003"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFF1203003"],"award-info":[{"award-number":["2022YFF1203003"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.taap.2024.117176","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T22:09:59Z","timestamp":1732831799000},"page":"117176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Model-based analysis for investigating the impact of tumor size, lymphocyte and neutrophil on the survival of breast cancer 4T1 tumor-bearing mice"],"prefix":"10.1016","volume":"494","author":[{"given":"Qing-yu","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-yu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-zhe","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-yao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-sheng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.taap.2024.117176_bb0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/psp4.12542","article-title":"Tumor growth dynamic modeling in oncology drug development and regulatory approval: past, present, and future opportunities","volume":"9","author":"Al-Huniti","year":"2020","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2024.117176_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.25122\/jml-2021-0108","article-title":"Triple-negative breast cancer: current treatment strategies and factors of negative prognosis","volume":"15","author":"Baranova","year":"2022","journal-title":"J. Med. Life"},{"issue":"12","key":"10.1016\/j.taap.2024.117176_bb0015","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1177\/0962280218808821","article-title":"Joint longitudinal and time-to-event models for multilevel hierarchical data","volume":"28","author":"Brilleman","year":"2019","journal-title":"Stat. Methods Med. Res."},{"issue":"2","key":"10.1016\/j.taap.2024.117176_bb0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaad.2016.02.1241","article-title":"Prevention and management of glucocorticoid-induced side effects: a comprehensive review: ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients","volume":"76","author":"Caplan","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.taap.2024.117176_bb0025","doi-asserted-by":"crossref","first-page":"1180810","DOI":"10.3389\/fimmu.2023.1180810","article-title":"Neutrophil diversity in inflammation and cancer","volume":"14","author":"Carnevale","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.taap.2024.117176_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/nu15030727","article-title":"Nutritional interventions during chemotherapy for pancreatic cancer: a systematic review of prospective studies","volume":"15","author":"Cintoni","year":"2023","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.taap.2024.117176_bb0035","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol."},{"issue":"24","key":"10.1016\/j.taap.2024.117176_bb0040","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1200\/JCO.2002.02.140","article-title":"Model of chemotherapy-induced myelosuppression with parameter consistency across drugs","volume":"20","author":"Friberg","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.taap.2024.117176_bb0045","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s12350-014-9908-2","article-title":"Survival analysis and regression models","volume":"21","author":"George","year":"2014","journal-title":"J. Nucl. Cardiol."},{"issue":"5 Suppl 10","key":"10.1016\/j.taap.2024.117176_bb0050","first-page":"32","article-title":"Gemcitabine safety overview","volume":"23","author":"Green","year":"1996","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.taap.2024.117176_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2013.18","article-title":"A time to event tutorial for pharmacometricians","volume":"2","author":"Holford","year":"2013","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2024.117176_bb0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ajhp\/54.2.162","article-title":"Gemcitabine: a cytidine analogue active against solid tumors","volume":"54","author":"Hui","year":"1997","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"1","key":"10.1016\/j.taap.2024.117176_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4143\/crt.2017.307","article-title":"The generation and application of patient-derived xenograft model for cancer research","volume":"50","author":"Jung","year":"2018","journal-title":"Cancer Res. Treat."},{"issue":"9","key":"10.1016\/j.taap.2024.117176_bb0070","first-page":"6","article-title":"Basic concepts in population modeling, simulation, and model-based drug development","volume":"1","author":"Mould","year":"2012"},{"issue":"7749","key":"10.1016\/j.taap.2024.117176_bb0075","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-019-1019-4","article-title":"Glucocorticoids promote breast cancer metastasis","volume":"567","author":"Obradovi\u0107","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.taap.2024.117176_bb0080","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.taap.2024.117176_bb0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-4939-2895-8_14","article-title":"Glucocorticoids and Cancer","volume":"872","author":"Pufall","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.taap.2024.117176_bb0090","first-page":"6","article-title":"Corticosteroid use in neuro-oncology: an update","volume":"2","author":"Roth","year":"2015","journal-title":"Neurooncol. Pract."},{"key":"10.1016\/j.taap.2024.117176_bb0095","first-page":"1","article-title":"The evolution of clinical trials in metastatic breast cancer: design features and endpoints that matter","volume":"40","author":"Seidman","year":"2020","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"3","key":"10.1016\/j.taap.2024.117176_bb0100","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1158\/0008-5472.CAN-03-2524","article-title":"Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents","volume":"64","author":"Simeoni","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2024.117176_bb0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40425-016-0165-6","article-title":"Clinical significance of tumor-infiltrating lymphocytes in breast cancer","volume":"4","author":"Stanton","year":"2016","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.taap.2024.117176_bb0110","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/cge.13900","article-title":"Molecular intrinsic versus clinical subtyping in breast cancer: a comprehensive review","volume":"99","author":"Szymiczek","year":"2021","journal-title":"Clin. Genet."},{"issue":"4","key":"10.1016\/j.taap.2024.117176_bb0115","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/cpt.1450","article-title":"Association between tumor size kinetics and survival in patients with urothelial carcinoma treated with atezolizumab: implication for patient follow-up","volume":"106","author":"Tardivon","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.taap.2024.117176_bb0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00430-016-0450-5","article-title":"Effective immunosuppression with dexamethasone phosphate in the galleria mellonella larva infection model resulting in enhanced virulence of Escherichia coli and Klebsiella pneumoniae","volume":"205","author":"Torres","year":"2016","journal-title":"Med. Microbiol. Immunol."},{"issue":"5","key":"10.1016\/j.taap.2024.117176_bb0125","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/jcsm.12220","article-title":"The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis","volume":"8","author":"Vagnildhaug","year":"2017","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.taap.2024.117176_bb0130","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/aps.2016.39","article-title":"Dexamethasone suppresses the growth of human non-small cell lung cancer via inducing estrogen sulfotransferase and inactivating estrogen","volume":"37","author":"Wang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"9","key":"10.1016\/j.taap.2024.117176_bb0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11095-019-2660-1","article-title":"Model-based analysis of treatment effects of paclitaxel microspheres in a microscopic peritoneal carcinomatosis model in mice","volume":"36","author":"Xie","year":"2019","journal-title":"Pharm. Res."},{"issue":"48","key":"10.1016\/j.taap.2024.117176_bb0140","first-page":"e36315","article-title":"Peripheral blood inflammatory indexes in breast cancer: A review","volume":"102","author":"Xie","year":"2023"},{"key":"10.1016\/j.taap.2024.117176_bb0145","doi-asserted-by":"crossref","first-page":"115118","DOI":"10.1016\/j.taap.2020.115118","article-title":"Dexamethasone inhibits pancreatic tumor growth in preclinical models: involvement of activating glucocorticoid receptor","volume":"401","author":"Yao","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2024.117176_bb0150","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41401-022-00960-0","article-title":"An integrated PK\/PD model investigating the impact of tumor size and systemic safety on animal survival in SW1990 pancreatic cancer xenograft","volume":"44","author":"Yao","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.taap.2024.117176_bb0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13048-022-00977-3","article-title":"Peripheral lymphocyte populations in ovarian cancer patients and correlations with clinicopathological features","volume":"15","author":"Ye","year":"2022","journal-title":"J. Ovarian Res."},{"issue":"12","key":"10.1016\/j.taap.2024.117176_bb0160","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1002\/jps.24629","article-title":"Semi-mechanism-based pharmacokinetic\/pharmacodynamic model for the combination use of dexamethasone and gemcitabine in breast cancer","volume":"104","author":"Yuan","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.taap.2024.117176_bb0165","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/bmc.3316","article-title":"Development and validation of a highly sensitive LC-MS\/MS method for the determination of dexamethasone in nude mice plasma and its application to a pharmacokinetic study","volume":"29","author":"Yuan","year":"2015","journal-title":"Biomed. Chromatogr."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24003752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24003752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T13:57:52Z","timestamp":1734011872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24003752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":33,"alternative-id":["S0041008X24003752"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.117176","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Model-based analysis for investigating the impact of tumor size, lymphocyte and neutrophil on the survival of breast cancer 4T1 tumor-bearing mice","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.117176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117176"}}